The dual adverse effects of TGF-β secretion on tumor progression
- 1 November 2005
- journal article
- editorial
- Published by Elsevier in Cancer Cell
- Vol. 8 (5) , 349-350
- https://doi.org/10.1016/j.ccr.2005.10.018
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- A functional analysis of the putative polymorphisms A91V and N252S and 22 missense perforin mutations associated with familial hemophagocytic lymphohistiocytosisBlood, 2005
- The Functional Basis for Hemophagocytic Lymphohistiocytosis in a Patient with Co-inherited Missense Mutations in the Perforin (PFN1) GeneThe Journal of Experimental Medicine, 2004
- Cutting Edge: Granzymes A and B Are Not Essential for Perforin-Mediated Tumor RejectionThe Journal of Immunology, 2003
- Functional significance of the perforin/granzyme cell death pathwayNature Reviews Immunology, 2002
- Immune-mediated eradication of tumors through the blockade of transforming growth factor-β signaling in T cellsNature Medicine, 2001
- IFNγ and lymphocytes prevent primary tumour development and shape tumour immunogenicityNature, 2001
- Perforin and interferon-γ activities independently control tumor initiation, growth, and metastasisBlood, 2001
- Perforin-Mediated Cytotoxicity Is Critical for Surveillance of Spontaneous LymphomaThe Journal of Experimental Medicine, 2000
- Abrogation of TGFβ Signaling in T Cells Leads to Spontaneous T Cell Differentiation and Autoimmune DiseaseImmunity, 2000
- Perforin Gene Defects in Familial Hemophagocytic LymphohistiocytosisScience, 1999